Advertisement
Advertisement

BHC

BHC logo

Bausch Health Companies Inc

5.39
USD
Sponsored
-0.11
-1.91%
May 21, 13:32 UTC -4
Open

BHC Earnings Reports

Positive Surprise Ratio

BHC beat 23 of 42 last estimates.

55%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.70B
/
$1.04
Implied change from Q1 26 (Revenue/ EPS)
+6.93%
/
+33.33%
Implied change from Q2 25 (Revenue/ EPS)
+6.68%
/
+14.29%

Bausch Health Companies Inc earnings per share and revenue

On Apr 29, 2026, BHC reported earnings of 0.78 USD per share (EPS) for Q1 26, beating the estimate of 0.69 USD, resulting in a 12.33% surprise. Revenue reached 2.52 billion, compared to an expected 2.43 billion, with a 3.76% difference. The market reacted with a +2.33% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 1.04 USD, with revenue projected to reach 2.70 billion USD, implying an increase of 33.33% EPS, and increase of 6.93% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BridgeBio Pharma, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.84
Surprise
-21.37%
logo
Dr. Reddy's Laboratories Limited - ADR
Report Date
May 12, 2026 For Q4 26
Estimate
$11.40
Actual
$2.65
Surprise
-76.76%
logo
Amphastar Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.71
Actual
$0.42
Surprise
-41.59%
logo
Personalis, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-5.42%
logo
Assembly Biosciences, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.54
Surprise
+7.12%
logo
Metagenomi Therapeutics, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-14.68%
FAQ
For Q1 2026, Bausch Health Companies Inc reported EPS of $0.78, beating estimates by 12.33%, and revenue of $2.52B, 3.76% above expectations.
The stock price moved up 2.33%, changed from $5.59 before the earnings release to $5.72 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 3 analysts, Bausch Health Companies Inc is expected to report EPS of $1.04 and revenue of $2.70B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement